Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121


An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection.

Peng T, Zhu J, Phasouk K, Koelle DM, Wald A, Corey L.

J Virol. 2012 Oct;86(19):10587-96. doi: 10.1128/JVI.01237-12.


Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.

Zhu J, Peng T, Johnston C, Phasouk K, Kask AS, Klock A, Jin L, Diem K, Koelle DM, Wald A, Robins H, Corey L.

Nature. 2013 May 23;497(7450):494-7. doi: 10.1038/nature12110. Erratum in: Nature. 2013 Aug 8;500(7461):242.


Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.

Zhu J, Koelle DM, Cao J, Vazquez J, Huang ML, Hladik F, Wald A, Corey L.

J Exp Med. 2007 Mar 19;204(3):595-603.


Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.

van Velzen M, Jing L, Osterhaus AD, Sette A, Koelle DM, Verjans GM.

PLoS Pathog. 2013 Aug;9(8):e1003547. doi: 10.1371/journal.ppat.1003547.


Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Johnston C, Zhu J, Jing L, Laing KJ, McClurkan CM, Klock A, Diem K, Jin L, Stanaway J, Tronstein E, Kwok WW, Huang ML, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, Corey L.

J Virol. 2014 May;88(9):4921-31. doi: 10.1128/JVI.03285-13.


Persistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tract.

Posavad CM, Zhao L, Mueller DE, Stevens CE, Huang ML, Wald A, Corey L.

Mucosal Immunol. 2015 Jan;8(1):115-26. doi: 10.1038/mi.2014.47.


Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.

Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Koelle DM, Wald A, Corey L.

Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18973-8. doi: 10.1073/pnas.1006614107.


Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions.

Nelson MH, Bird MD, Chu CF, Johnson AJ, Friedrich BM, Allman WR, Milligan GN.

J Reprod Immunol. 2011 Apr;89(1):10-7. doi: 10.1016/j.jri.2011.01.013.


Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia.

Derfuss T, Segerer S, Herberger S, Sinicina I, Hüfner K, Ebelt K, Knaus HG, Steiner I, Meinl E, Dornmair K, Arbusow V, Strupp M, Brandt T, Theil D.

Brain Pathol. 2007 Oct;17(4):389-98.


Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.

Klenner L, Hafezi W, Clausen BE, Lorentzen EU, Luger TA, Beissert S, Kühn JE, Loser K.

J Invest Dermatol. 2015 Nov;135(11):2676-87. doi: 10.1038/jid.2015.225.


A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge.

Zhang X, Chentoufi AA, Dasgupta G, Nesburn AB, Wu M, Zhu X, Carpenter D, Wechsler SL, You S, BenMohamed L.

Mucosal Immunol. 2009 Mar;2(2):129-43. doi: 10.1038/mi.2008.81.


CD8(+) T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection.

Wakim LM, Jones CM, Gebhardt T, Preston CM, Carbone FR.

Immunol Cell Biol. 2008 Nov-Dec;86(8):666-75. doi: 10.1038/icb.2008.47.


CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons.

Liu T, Khanna KM, Chen X, Fink DJ, Hendricks RL.

J Exp Med. 2000 May 1;191(9):1459-66.

Items per page

Supplemental Content

Support Center